The results of the present study suggest that the rs1283671 and rs1283720 SNPs of the ANGPT1 gene could be clinical markers that predict analgesic requirements, in which the minor alleles of these SNPs are possibly associated with lower opioid sensitivity and thus greater requirements for opioid analgesics in the treatment of cancer pain. The gene discussed is ANGPT1; the disease is cancer.